STOCKHOLM – Elekta today announced a partnership with MSD to develop digital patient monitoring for people with advanced renal cell carcinoma , using Elekta’s Kaiku Health solution, a digital.
Elekta partners with MSD to enhance kidney cancer care using digital solutionsSTOCKHOLM – Elekta (EKTA-B.ST) today announced a partnership with MSD (Merck & Co., Inc., Rahway, N.J., USA) to develop digital patient monitoring for people with advanced renal cell carcinoma (RCC), using Elekta’s Kaiku He.
Global Digital Therapeutics IndustryAs per Future Market Insights, the Global Digital Therapeutics Industry is forecast to reach US$ 4.8 Bn in 2022, with sales growing at an impressive 24.4% CAGR over the forecast period. The market size will reach US$ 42.5 Bn by 2032.To infiltrate and disrupt the healthcare sector,.
/PRNewswire/ The "Global Precision Medicine Business Investment Opportunities" report is now available at ResearchAndMarkets.com. This report furnishes a.
As per Future Market Insights, the global Digital Therapeutics Market is forecast to reach US$ 4.8 Bn in 2022, with sales growing at an impressive 24.4% CAGR over the forecast period. The market size will reach US$ 42.5 Bn by 2032.To infiltrate and disrupt the healthcare sector, IT companies are producing and acquir.